Assessing the Health Economic Outcomes from Commercially Insured Relapsing Multiple Sclerosis Patients Who Switched from Other Disease-Modifying Therapies to Teriflunomide, in the United States
Lita Araujo,1 Srikanth Kyatham,2 Kristen G Bzdek,1 Keiko Higuchi,1 Nupur Greene1 1Neurology and Immunology, Sanofi, Cambridge, MA, USA; 2Axtria Inc, Berkeley Heights, NJ, USACorrespondence: Lita Araujo, Neurology and Immunology, Sanofi, 450 Water Street, Cambridge, MA, 02141, USA, Tel +1 617 937 992...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Dove Medical Press,
2023-05-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|